New Mexico Cancer Care Alliance [clinicaltrials_resource:fbf3b174dc1931f6ba49869c93fc8ca0]
affiliation [clinicaltrials_vocabulary:affiliation]
clinicaltrials:NCT00322894clinicaltrials:NCT00391586Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers [clinicaltrials:NCT00832871]clinicaltrials:NCT00945139clinicaltrials:NCT00947739clinicaltrials:NCT00996346clinicaltrials:NCT01009203clinicaltrials:NCT01011075clinicaltrials:NCT01032850clinicaltrials:NCT01202890clinicaltrials:NCT01275183clinicaltrials:NCT01542047clinicaltrials:NCT01607554clinicaltrials:NCT01765803Pelvic Floor Muscle Training in Treating Urinary Incontinence in Gynecologic Cancer Survivors [clinicaltrials:NCT01806350]clinicaltrials:NCT01821833clinicaltrials:NCT01889420
collaborator [clinicaltrials_vocabulary:collaborator]
Combination Paclitaxel, Carboplatin and Temozolomide [clinicaltrials:NCT00249964]Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen [clinicaltrials:NCT00250029]A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec [clinicaltrials:NCT00250042]Clinical Benefit of Topoisomerase Downregulation [clinicaltrials:NCT00250094]clinicaltrials:NCT00250718Comparison of Aprepitant Versus Gabapentin in the Prevention of Delayed Nausea and Vomiting [clinicaltrials:NCT00250744]Prostate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic Secretions [clinicaltrials:NCT00250757]Gemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per Microliter [clinicaltrials:NCT00250822]clinicaltrials:NCT00250835Phase IB Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue Sarcoma [clinicaltrials:NCT00276055]Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma [clinicaltrials:NCT00277017]A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With Taxanes [clinicaltrials:NCT00277043]Clinical Predictors of Survival in Cancer Patients With Metastatic Solid Tumors [clinicaltrials:NCT00322634]Differences in Trends Malignant Germ Cell Tumors in Males and Females: A SEER Population-based Study [clinicaltrials:NCT00322790]Chart Review of Treatments Received by Patients Diagnosed With Soft Tissue Sarcoma [clinicaltrials:NCT00322855]clinicaltrials:NCT00322894Trends in Incidence and Survivals for Ovarian Germ Cell Tumors: A 27-Year Population-Based Study [clinicaltrials:NCT00323726]clinicaltrials:NCT00391586A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients [clinicaltrials:NCT00659269]clinicaltrials:NCT00809458Observational Study of Best Supportive Care With or Without Surgery, Chemo or Radiotherapy in Pts With Carcinoma of Lung [clinicaltrials:NCT00822016]clinicaltrials:NCT00832520The Response of Serum 25-Hydroxyvitamin D to Incidental Ultraviolet Light Exposure [clinicaltrials:NCT00832533]clinicaltrials:NCT00832637Phase II Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Tumors of the Lung [clinicaltrials:NCT00832780]Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers [clinicaltrials:NCT00832871]clinicaltrials:NCT00871169clinicaltrials:NCT00945139clinicaltrials:NCT00947739Use of Hydralzaine and Valproic Acid in Advanced Solid Tumor Malignancies [clinicaltrials:NCT00996060]clinicaltrials:NCT00996346A Phase 1 Protocol of 5-Azacytidine and Erlotinib in Advanced Solid Tumor Malignancies [clinicaltrials:NCT00996515]Ultraviolet Light Exposure and Immunosuppression in Cutaneous Melanoma [clinicaltrials:NCT00996827]clinicaltrials:NCT01009203clinicaltrials:NCT01009515Comparison of Standard of Care or Treatment on Protocol [clinicaltrials:NCT01010334]clinicaltrials:NCT01011075A Study of Imatinib and Valproic Acid in Patients With Chronic Myelogenous Leukemia (CML) [clinicaltrials:NCT01011998]clinicaltrials:NCT01030757clinicaltrials:NCT01032850
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
Combination Paclitaxel, Carboplatin and Temozolomide [clinicaltrials:NCT00249964]Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen [clinicaltrials:NCT00250029]A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec [clinicaltrials:NCT00250042]Clinical Benefit of Topoisomerase Downregulation [clinicaltrials:NCT00250094]clinicaltrials:NCT00250718Comparison of Aprepitant Versus Gabapentin in the Prevention of Delayed Nausea and Vomiting [clinicaltrials:NCT00250744]Prostate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic Secretions [clinicaltrials:NCT00250757]Gemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per Microliter [clinicaltrials:NCT00250822]clinicaltrials:NCT00250835Phase IB Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue Sarcoma [clinicaltrials:NCT00276055]Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma [clinicaltrials:NCT00277017]A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With Taxanes [clinicaltrials:NCT00277043]Clinical Predictors of Survival in Cancer Patients With Metastatic Solid Tumors [clinicaltrials:NCT00322634]Differences in Trends Malignant Germ Cell Tumors in Males and Females: A SEER Population-based Study [clinicaltrials:NCT00322790]Chart Review of Treatments Received by Patients Diagnosed With Soft Tissue Sarcoma [clinicaltrials:NCT00322855]clinicaltrials:NCT00322894Trends in Incidence and Survivals for Ovarian Germ Cell Tumors: A 27-Year Population-Based Study [clinicaltrials:NCT00323726]clinicaltrials:NCT00391586A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients [clinicaltrials:NCT00659269]clinicaltrials:NCT00809458Observational Study of Best Supportive Care With or Without Surgery, Chemo or Radiotherapy in Pts With Carcinoma of Lung [clinicaltrials:NCT00822016]clinicaltrials:NCT00832520The Response of Serum 25-Hydroxyvitamin D to Incidental Ultraviolet Light Exposure [clinicaltrials:NCT00832533]clinicaltrials:NCT00832637Phase II Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Tumors of the Lung [clinicaltrials:NCT00832780]Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers [clinicaltrials:NCT00832871]clinicaltrials:NCT00871169clinicaltrials:NCT00945139clinicaltrials:NCT00947739Use of Hydralzaine and Valproic Acid in Advanced Solid Tumor Malignancies [clinicaltrials:NCT00996060]clinicaltrials:NCT00996346A Phase 1 Protocol of 5-Azacytidine and Erlotinib in Advanced Solid Tumor Malignancies [clinicaltrials:NCT00996515]Ultraviolet Light Exposure and Immunosuppression in Cutaneous Melanoma [clinicaltrials:NCT00996827]clinicaltrials:NCT01009203clinicaltrials:NCT01009515Comparison of Standard of Care or Treatment on Protocol [clinicaltrials:NCT01010334]clinicaltrials:NCT01011075A Study of Imatinib and Valproic Acid in Patients With Chronic Myelogenous Leukemia (CML) [clinicaltrials:NCT01011998]clinicaltrials:NCT01030757clinicaltrials:NCT01032850
source [clinicaltrials_vocabulary:source]
New Mexico Cancer Care Alliance [clinicaltrials_resource:fbf3b174dc1931f6ba49869c93fc8ca0]
Bio2RDF identifier
fbf3b174dc1931f6ba49869c93fc8ca0
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:fbf3b174dc1931f6ba49869c93fc8ca0
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:fbf3b174dc1931f6ba49869c93fc8ca0
title
New Mexico Cancer Care Alliance
@en
type
label
New Mexico Cancer Care Allianc ...... 3b174dc1931f6ba49869c93fc8ca0]
@en